Inventisbio Co., Ltd
Clinical trials sponsored by Inventisbio Co., Ltd, explained in plain language.
-
New pill offers hope for taming the Flare-Ups of lupus
Disease control Not yet recruitingThis study is testing an experimental pill called D-2570 to see if it can help control the disease activity in people with active systemic lupus erythematosus (SLE). About 120 participants will be randomly assigned to take either the new drug or a placebo pill once a day for near…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New pill aims to clear skin and improve life for psoriasis patients
Disease control Not yet recruitingThis study is testing an investigational oral medication called D-2570 for people with moderate to severe plaque psoriasis. It will compare the new drug's effectiveness and safety against a placebo (a dummy pill) and an existing approved medication. The goal is to see if D-2570 c…
Phase: PHASE3 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists trace new Drug's journey through the body
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new drug called D-2570 is processed by the body. Eight healthy Chinese male volunteers will receive a single dose containing a tiny, safe amount of radioactive tracer. Researchers will carefully measure how the drug is broken down a…
Phase: PHASE1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC